Evidence map›Paper›PMID 31591121›Full record

ArticleAntimicrobial agents and chemotherapy2019

Autophagy Induction by a Small Molecule Inhibits

Toni A Nagy, Joaquin L J Quintana, Abigail L Reens, Amy L Crooks, Corrella S Detweiler

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Autophagy is essential for anti-Frontiers in microbiology · 2026
    Article
  4. Antibiotic Alternatives and Next-Generation Therapeutics forAntibiotics (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Clofazimine Reduces the Survival ofACS infectious diseases · 2020
    Article
  14. Review
  15. Frontiers in microbiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Toni A NagyDepartment of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309 toni.nagy@colorado.edu.
Joaquin L J QuintanaDepartment of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309.
Abigail L ReensDepartment of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309.
Amy L CrooksDepartment of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309.
Corrella S DetweilerDepartment of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309.
University of Colorado Boulder · US

Funding

A Novel Screen for Antibacterials that Are Non-Toxic to MammalsR33AI121365 · NIAID · UNIVERSITY OF COLORADO · PI DETWEILER, CORRELLA S, WANG, XIANG · 2018 to 2020
$1.4M
A Novel Screen for Antibacterials that Are Non-Toxic to MammalsR21AI121365 · NIAID · UNIVERSITY OF COLORADO · PI DETWEILER, CORRELLA S, WANG, XIANG · 2016 to 2017
$412k
NIAID NIH HHS R21 AI121365NIAID NIH HHS R33 AI121365
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31591121
PMCPMC6879225
OpenAlexW2978543557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.